These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38415248)

  • 1. SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity.
    Ilangumaran S; Gui Y; Shukla A; Ramanathan S
    Front Immunol; 2024; 15():1362224. PubMed ID: 38415248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOCS1: Regulator of T Cells in Autoimmunity and Cancer.
    Ilangumaran S; Bobbala D; Ramanathan S
    Curr Top Microbiol Immunol; 2017; 410():159-189. PubMed ID: 28900678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity.
    Bidgood GM; Keating N; Doggett K; Nicholson SE
    Front Immunol; 2024; 15():1419951. PubMed ID: 38947335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS1 in cancer: An oncogene and a tumor suppressor.
    Beaurivage C; Champagne A; Tobelaim WS; Pomerleau V; Menendez A; Saucier C
    Cytokine; 2016 Jun; 82():87-94. PubMed ID: 26811119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.
    Alice AF; Kramer G; Bambina S; Baird JR; Bahjat KS; Gough MJ; Crittenden MR
    J Immunol; 2018 Jan; 200(1):177-185. PubMed ID: 29150567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-component lipid nanoparticles for engineering SOCS1 gene-silenced dendritic cells to boost tumor immunotherapy.
    Yu Z; Wu M; Huang Y; Wang Y; Chen Y; Long Q; Lin Z; Xue L; Ju C; Zhang C
    Biomater Sci; 2022 Dec; 11(1):263-277. PubMed ID: 36440740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressors of cytokine signaling: Potential immune checkpoint molecules for cancer immunotherapy.
    Chikuma S; Kanamori M; Mise-Omata S; Yoshimura A
    Cancer Sci; 2017 Apr; 108(4):574-580. PubMed ID: 28188673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
    Kajiyama T; Serada S; Fujimoto M; Ohkawara T; Komori M; Hyodo M; Naka T
    Anticancer Res; 2022 Jul; 42(7):3361-3372. PubMed ID: 35790291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
    Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
    J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
    Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
    Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One Gene, Many Facets: Multiple Immune Pathway Dysregulation in SOCS1 Haploinsufficiency.
    Körholz J; Gabrielyan A; Sowerby JM; Boschann F; Chen LS; Paul D; Brandt D; Kleymann J; Kolditz M; Toepfner N; Knöfler R; Jacobsen EM; Wolf C; Conrad K; Röber N; Lee-Kirsch MA; Smith KGC; Mundlos S; Berner R; Dalpke AH; Schuetz C; Rae W
    Front Immunol; 2021; 12():680334. PubMed ID: 34421895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL4Rα and IL17A Blockade Rescue Autoinflammation in SOCS1 Haploinsufficiency.
    Gruber C; Lee A; Buta S; Khattri S; Gottlieb AB; Frost JM; Bowcock AM; Ho HE; Bogunovic D
    J Clin Immunol; 2023 Dec; 44(1):36. PubMed ID: 38157076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
    Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
    Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS1 counteracts ROS-mediated survival signals and promotes apoptosis by modulating cell cycle to increase radiosensitivity of colorectal cancer cells.
    Ryu JY; Oh J; Kim SM; Kim WG; Jeong H; Ahn SA; Kim SH; Jang JY; Yoo BC; Kim CW; Lee CE
    BMB Rep; 2022 Apr; 55(4):198-203. PubMed ID: 35321782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
    Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
    Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of SOCS1 in tumor progression and therapeutic application.
    Zhang J; Li H; Yu JP; Wang SE; Ren XB
    Int J Cancer; 2012 May; 130(9):1971-80. PubMed ID: 22025331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS1 and its Potential Clinical Role in Tumor.
    Ying J; Qiu X; Lu Y; Zhang M
    Pathol Oncol Res; 2019 Oct; 25(4):1295-1301. PubMed ID: 30761449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic High-Density Lipoprotein-Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma.
    Yang C; Li Y; Yang Y; Ni Q; Zhang Z; Chai Y; Li J
    Angew Chem Int Ed Engl; 2023 Dec; 62(49):e202312603. PubMed ID: 37847126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.